Korean J Obstet Gynecol Search


Korean Journal of Obstetrics & Gynecology 2002;45(7):1236-1240.
Published online July 1, 2002.
A case of carcinosarcoma of uterine endometrium associated with Tamoxifen use in breast cancer patient.
Jun Mo Ahn, Shin Ah Kim, Seok Min Lee, Yun Hee Lee, Dae Won Kim, Jib Kwang Chung, Seong Uk Kim, Hwan Sung Joe, Im Soon Lee, Dong Won Kim
1Department of Obstetrics & Gynecology, College of Medicine, Soonchunhyung University, Seoul, Korea.
2Department of Anatomic Pathology, College of Medicine, Soonchunhyung University, Seoul, Korea.
Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have significant benificial effects in the treatment of breast cancer patients as hormonal therapy. However, there is evidence that tamoxifen may affect other hormone sensitive organs, including the uterus and ovaries. An increased risk of endometrial polyps, endometrial hyperplasia and endometrial cancer has been reported in tamoxifen treated women. We are able to make this report because we have experienced uterine endometrial carcinosarcoma which is developed in a patient treated with tamoxifen for five years following a modified radical mastectomy due to breast cancer in our hospital.
Key Words: Tamoxifen, Carcinosarcoma

Article category

Browse all articles >


Browse all articles >

Editorial Office
49-2 Chungmu-ro, Jung-gu, Seoul 04550, Korea
Tel: +82-2-2266-7238    Fax: +82-2-2277-5194    E-mail: journal@ogscience.org                

Copyright © 2023 by Korean Society of Obstetrics and Gynecology.

Developed in M2PI

Close layer
prev next